Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Carcinoma, Non-Small-Cell Lung 533Squamous Cell Carcinoma of Head and Neck 274Head and Neck Neoplasms 253Lung Neoplasms 238Uterine Cervical Neoplasms 178Stomach Neoplasms 168Esophageal Neoplasms 160Nasopharyngeal Carcinoma 123Urinary Bladder Neoplasms 116Esophageal Squamous Cell Carcinoma 115Neoplasms 113Small Cell Lung Carcinoma 104Breast Neoplasms 92Neoplasm Metastasis 90Ovarian Neoplasms 89Cholangiocarcinoma 76Carcinoma, Squamous Cell 76Pancreatic Neoplasms 72Biliary Tract Neoplasms 70Mesothelioma, Malignant 57Oropharyngeal Neoplasms 56Carcinoma 55Adenocarcinoma Of Esophagus 52Recurrence 47Parkinson Disease 4, Autosomal Dominant Lewy Body 47Carcinoma, Ovarian Epithelial 45Nasopharyngeal Neoplasms 41Lymphoma 41Adenocarcinoma of Lung 41Triple Negative Breast Neoplasms 38

Interventions

Radiotherapy 2Exercise 2Deglutition 2Cisplatin 2Carboplatin 2Brachytherapy 2Acupuncture Therapy 2tislelizumab 1epigallocatechin gallate 1dexamethasone acetate 1dexamethasone 21-phosphate 1auricularum 1Tablets 1Standard of Care 1Resistance Training 1Range of Motion, Articular 1Radiotherapy, Intensity-Modulated 1Radiation 1Pravastatin 1Paclitaxel 1Niacinamide 1Musculoskeletal Manipulations 1Lead 1Hyaluronic Acid 1Gastropexy 1Fundoplication 1Fluorouracil 1Fibroblast Growth Factor 7 1Esophagectomy 1Endoscopy, Digestive System 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Deglutition Disorders × Cisplatin × Clear all
NCT05596890 2022-11-28

PICCRT

Guangdong Provincial People's Hospital

Phase 2 Unknown
50 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma, Deglutition Disorders

NCT00193882 2017-07-12

Advanced Oesophageal Cancer Study to Compare Quality of Life and Palliation of Dysphagia.

Trans Tasman Radiation Oncology Group

Phase 3 Completed
220 enrolled
Gastrointestinal

Deglutition Disorders, Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡